Clinical Trial Update: Iceland Screens, Treats or Prevents Multiple Myeloma [NA]

View source ↗

Summary

The Iceland iStopMM trial (NCT03327597) investigates screening, treatment, or prevention strategies to reduce progression from Monoclonal Gammopathy of Undeterm…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Monoclonal Gammopathy of Undetermined Significance
• Multiple Myeloma

Snippet

Sponsor: University of Iceland | Conditions: Monoclonal Gammopathy of Undetermined Significance | NA | Status: ACTIVE_NOT_RECRUITING